KRISTI KENNON: Open Payments
NPI 1073923140 · GULFPORT, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,259 in 71 payments from 16 companies in 2025. Trend: 2023 $720 · 2024 $1,239 · 2025 $1,259
Food & beverage: $1,259
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $239 |
| AstraZeneca Pharmaceuticals LP | 10 | $208 |
| PFIZER INC. | 11 | $172 |
| Lilly USA, LLC | 8 | $131 |
| Viatris Specialty LLC | 5 | $99 |
| Amgen Inc. | 5 | $86 |
| Sumitomo Pharma America, Inc. | 5 | $84 |
| Lundbeck LLC | 3 | $52 |
| Xeris Pharmaceuticals, Inc. | 2 | $47 |
| GlaxoSmithKline, LLC. | 2 | $29 |
Products named: NURTEC ODT, MOUNJARO, YUPELRI, FARXIGA, GEMTESA, AIRSUPRA, UBRELVY, OTEZLA.
Industry payments across MS — which companies pay providers there.
